Premium
Astellas Pharma Inc (PK) (ALPMY)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Astellas and The Chris Klug Foundation Announce Winners of the 2015 Bounce Back Award PR Newswire NORTHBROOK, Ill. and ASPEN, Colo., June 4, 2015 NORTHBROOK, Ill. and ASPEN, Colo., June 4, 2015...
New Enzalutamide Data In Triple-negative Breast Cancer Presented At The 2015 American Society Of Clinical Oncology Annual Meeting PR Newswire TOKYO and NORTHBROOK, Ill., June 1, 2015 TOKYO and...
Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) - Results from Phase 1/2 trial...
Mirabegron As Add-On Treatment To Solifenacin Therapy Demonstrated Superior Results To Solifenacin Monotherapy In BESIDE Trial Data Presented in Plenary Session at AUA 2015 PR Newswire TOKYO and...
Astellas And Medivation Announce New Enzalutamide Data Presented At The 2015 American Urological Association Annual Meeting PR Newswire TOKYO and SAN FRANCISCO, May 17, 2015 TOKYO and SAN...
Astellas Announces New Data in Advanced Prostate and Breast Cancers, Acute Myeloid Leukemia, and Lung and Renal Cancers To Be Presented at 2015 ASCO Annual Meeting PR Newswire NORTHBROOK, Ill...
Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting PR Newswire NORTHBROOK, Ill., May 5, 2015 NORTHBROOK, Ill., May 5, 2015 /PRNewswire/...
Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics Exclusive Collaboration Includes Option for Astellas to Acquire Potenza PR Newswire TOKYO and...
Astellas Appoints Shontelle Dodson to Lead Medical Excellence Function PR Newswire TOKYO, April 6, 2015 TOKYO, April 6, 2015 /PRNewswire/ -- Astellas ("Astellas,") (Tokyo: 4503) today announced...
MD Anderson, Astellas Pharma Sign Option Agreement for Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia PR Newswire TOKYO and HOUSTON, April 3, 2015 TOKYO and HOUSTON, April 3, 2015...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.33 | -3.40206185567 | 9.7 | 9.756 | 9.12 | 197037 | 9.35825285 | DR |
| 4 | -0.55 | -5.54435483871 | 9.92 | 10.13 | 9.05 | 254642 | 9.53390836 | DR |
| 12 | -1.28 | -12.0187793427 | 10.65 | 11.03 | 9.05 | 289973 | 9.8649299 | DR |
| 26 | -2.13 | -18.5217391304 | 11.5 | 13.14 | 9.05 | 179941 | 10.40471441 | DR |
| 52 | -1.55 | -14.1941391941 | 10.92 | 13.14 | 9.05 | 244107 | 10.29942915 | DR |
| 156 | -8.13 | -46.4571428571 | 17.5 | 17.96 | 9.05 | 177652 | 12.21616471 | DR |
| 260 | -8.13 | -46.4571428571 | 17.5 | 18.47 | 9.05 | 138528 | 13.0661563 | DR |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
